Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary Events

JAMA - Journal of the American Medical Association- United States

doi 10.1001/jama.286.12.1468

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

American Medical Association (AMA)

Related search

Effects of Increasing Particle Size of Low-Density Lipoprotein on Restenosis After Coronary Stent Implantation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2008English

Gemfibrozil Reduced the Risk for Coronary Events in Men With Coronary Artery Disease and Low Levels of High Density Lipoprotein Cholesterol

Evidence-Based Medicine
Medicine
2000English

Impact of Adiponectin and Oxidized Low-Density Lipoprotein in Acute Coronary Syndrome

Journal of Contemporary Medical Sciences
2017English

Oxidized Low-Density Lipoprotein and Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

Direct Assessment of Plasma Low Density Lipoprotein and High Density Lipoprotein Cholesterol Levels and Coronary Heart Disease: Results From the Framingham Offspring Study

Atherosclerosis
Cardiovascular MedicineCardiology
2010English

Low-Density Lipoprotein Receptor (LDLR)

Science-Business eXchange
2010English

Low-Density Lipoprotein Receptor (LDLR)

Science-Business eXchange
2011English

Novel Regulators of Low-Density Lipoprotein Receptor and Circulating LDL-C for the Prevention and Treatment of Coronary Artery Disease

2012English

Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy